Becton Dickinson (BD)

Updated: 2026-07-20

Overview

Becton Dickinson (BD) is a leading multinational medical technology firm established in 1897, headquartered in Franklin Lakes, New Jersey. The company operates across three segments: BD Medical, BD Life Sciences, and BD Interventional. Its innovations include safety-engineered syringes, automated diagnostic platforms, and cell analysis tools, serving hospitals, labs, and pharmacies globally. BD holds over 10,000 patents and collaborates with healthcare providers to reduce infection risks and improve workflow efficiency. Notable acquisitions, such as C. R. Bard and CareFusion, have expanded its portfolio in vascular access and surgical products. The company adheres to ISO 13485 and FDA 21 CFR Part 820 standards.

Structure and Working Principle

BD's products integrate mechanical, electronic, and fluidic components. For example, its BD Posiflush™ syringes use a luer-lock mechanism to prevent needlestick injuries, while BD FACSCanto™ flow cytometers employ laser optics and digital signal processing for cell analysis. Infusion pumps like the BD Alaris™ system feature dose-error reduction software and modular designs for ICU and ambulatory care. Reagents and culture media in BD BACTEC™ systems utilize fluorescent sensors to detect microbial growth, automating laboratory workflows.

Key Features

BD emphasizes safety, accuracy, and scalability. SafetyGlide™ needles retract post-use to minimize sharps exposure. BD Max™ molecular diagnostics platforms offer random-access testing with ≤2% coefficient of variation for reproducibility. Products are validated for compatibility with EHR systems like Epic and Cerner. The BD Kiestra™ lab automation line reduces manual steps in microbiology processing, increasing throughput by 50–70% compared to traditional methods.

Application Areas

Hospitals deploy BD Pyxis™ medication dispensers to manage narcotics inventory, while research labs use BD Horizon™ dyes for multicolor flow cytometry. In home care, BD Nano™ pen needles provide low-pain diabetes management. Pharma companies leverage BD Hypak™ prefillable syringes for biologics delivery. During COVID-19, BD contributed to vaccine development with specialized glass vials and BD Rhapsody™ single-cell analysis systems.

Maintenance and Precautions

Calibrate BD diagnostic instruments quarterly using certified reference materials. For BD Insyte™ IV catheters, follow aseptic techniques and replace dressings per CDC guidelines. Avoid exposing BD Vacutainer™ blood collection tubes to extreme temperatures. Reusable components like BD FACS™ sorters require weekly decontamination with 10% bleach solutions. Always consult technical manuals for device-specific protocols.

B2B Procurement Guide

For bulk orders (500+ units), BD offers tiered pricing through authorized distributors like Henry Schein and McKesson. Request Material Safety Data Sheets (MSDS) for chemical products like BD BBL™ culture media. Lead times range from 2 weeks for standard items to 6 months for customized solutions. Evaluate service contracts for high-value equipment, typically covering 5–10% of the purchase price annually. Check regional regulatory approvals (e.g., China NMPA, EU MDR) before import.